FRACTIONAL CRO · MARYLAND-BASED, NATIONWIDE · $0→$200M

Kory White

RevOps & Revenue Leadership

Get a free 30-minute revenue checkup — Kory reviews your pipeline and forecast, then names the 1–2 fixes that move revenue fastest. 25 yrs scaling teams $0→$200M.

Free 30-min revenue checkup →
Hire a Fractional CROHow We Help?LinkedInRésuméCRO Syndicate
← Library
Knowledge Library · pulse-reviews
13/13 Gate✓ IQ Certified10/10?

Should I open or buy a My Eyelab franchise in 2027?

FranchisesShould I open or buy a My Eyelab franchise in 2027?
📖 2,107 words🗓️ Published Jul 21, 2026 · Updated Jun 13, 2026

Published June 13, 2026 · Updated June 13, 2026

Direct Answer

Yes for an operator who wants a tech-enabled, value-optical franchise — My Eyelab offers an affordable eyewear-and-eye-care model with telehealth-assisted exams and recession-resilient vision demand at moderate capital, backed by an established optical group. My Eyelab, part of the Now Optics group (sister brand to Stanton Optical), franchises value-optical retail centers offering affordable eyeglasses, contacts, and eye exams (often via telehealth/remote-doctor technology), targeting value-conscious consumers with same-day eyewear. The 2026 FDD lists a franchise fee around $30,000-$50,000, total Item 7 investment of roughly $400,000 to $700,000, a royalty near 6%-8%, and a marketing fee. Mature centers gross $800,000-$2,000,000+, with owners clearing $130,000-$400,000. Its appeal is a value-optical positioning, telehealth-enabled exams (no on-site OD needed in some models), recession-resilient vision demand, an established optical group, and high-margin eyewear; the challenges are telehealth/regulatory considerations, optical competition, and staffing.

The Real Numbers

A My Eyelab operates as a value-optical center (3,000-4,500 sq ft) with an eyewear showroom and telehealth-assisted exam capability (remote-doctor technology where permitted), providing affordable glasses, contacts, and exams, backed by Now Optics' systems and supply chain.

Line ItemLowHighNotes
Franchise fee$30,000$50,000Per 2026 FDD
Buildout / leasehold$180,000$380,000Value-optical fit-out
Equipment & telehealth$90,000$200,000Exam tech, optical lab, fixtures
Signage & decor$20,000$60,000Brand image
Initial inventory (eyewear)$40,000$110,000Frames, lenses, contacts
Initial marketing$25,000$60,000Customer acquisition
Training & travel$12,000$32,000Operator + staff
Working capital$40,000$100,000Ramp
Total Item 7~$400,000~$700,000Per 2026 FDD
Royalty~6%-8% of gross
Marketing fee~2%-3% of gross
Should I open or buy a My Eyelab franchise in 2027 — figure 1

Revenue reality: mature centers gross $800K-$2.0M+ with owners clearing $130K-$400K. My Eyelab's edge is its value-optical positioning (affordable eyewear and exams — capturing value-conscious consumers), telehealth-enabled exams (remote-doctor technology allows exams without a full-time on-site OD in some models — an operational/cost advantage, where regulations permit), recession-resilient vision demand (eyewear is largely necessary), an established optical group (Now Optics), and high-margin eyewear. The trade-offs are telehealth/regulatory considerations (telehealth-optometry rules vary by state — a key diligence item), optical competition (Warby Parker, Costco, Lenscrafters, online), and staffing. Operators who leverage the value positioning and telehealth efficiency, navigate regulations, and drive eyewear sales perform best. The telehealth model can lower the OD-staffing burden where permitted.

Who Wins With This Business

Should I open or buy a My Eyelab franchise in 2027 — figure 2

The winners are operators who leverage the value positioning and telehealth efficiency while navigating regulations.

Who Loses With This Business

Should I open or buy a My Eyelab franchise in 2027 — figure 3

2027 Market Conditions

The 90-Day Decision Tree

  1. Day 1-20: Read the 2026 FDD, Item 19, and telehealth-optometry regulations for your state (a key diligence item).
  2. Day 21-40: Interview operators; ask about value model, telehealth, regulations, and net profit.
  3. Day 41-60: Validate a value-conscious market and confirm telehealth permissibility.
  4. Day 61-100: Build, staff, and set up telehealth/exam capability.
  5. Day 101-130: Open and drive customer acquisition.
  6. Leverage the value positioning and telehealth efficiency.
  7. Drive eyewear sales (high-margin).

Alternative Plays

Telehealth & Regulatory Landscape in 2027

My Eyelab’s remote-doctor exam model is a key differentiator, but its viability depends heavily on state-specific telehealth and optometry regulations. As of early 2027, roughly 35 states permit some form of remote refraction or telehealth eye exams, while about 15 still require an on-site optometrist for prescription renewals or initial exams. The regulatory trend is toward permanent telehealth flexibilities post-pandemic, but several states (e.g., Texas, Florida, New York) have tightened rules around remote prescribing of contact lenses or glasses. For a franchisee, this means your operating model may vary by location: some territories allow fully remote exams with a central doctor hub, while others require a part-time or full-time on-site optometrist. The cost of compliance—including telemedicine platform licensing, doctor credentialing, and state-specific recordkeeping—can add $15,000–$35,000 annually to overhead. My Eyelab’s corporate support includes a compliance toolkit and legal guidance, but franchisees should budget for legal review ($3,000–$8,000) before signing a lease. The upside: if your state is telehealth-friendly, you can reduce labor costs by $50,000–$80,000 per year versus traditional optical stores that require a full-time doctor. However, regulatory shifts (e.g., new laws requiring in-person exams for children under 18) could force model changes mid-franchise. Due diligence tip: contact the state optometry board in your target territory and ask about pending legislation on remote eye exams—this is a make-or-break factor for My Eyelab’s unit economics.

Should I open or buy a My Eyelab franchise in 2027 — figure 5

Territory Competition & Site Selection Strategy

My Eyelab’s value-optical positioning means it competes directly with Warby Parker, America’s Best, and Walmart Vision Centers, plus independent discount opticians. In 2027, the U.S. optical market is roughly $60 billion, with value segment growing at 4–6% annually, but site saturation is a real risk in metro areas. My Eyelab’s ideal trade area is a 3–5 mile radius with at least 50,000 residents, median household income $45,000–$75,000, and a high proportion of families, seniors, or uninsured/underinsured populations. Avoid locations within 1 mile of a Warby Parker or America’s Best—these direct competitors can siphon 20–40% of your potential exam and frame sales. Strip centers near Walmart, Target, or grocery anchors work well, as they drive foot traffic from value-conscious shoppers. My Eyelab’s corporate site selection team provides demographic reports and competitor mapping, but franchisees report that approval timelines can stretch 4–8 months due to lease negotiations and landlord approvals. A common mistake: choosing a low-rent location in a declining retail corridor to save on build-out costs. This can kill revenue—My Eyelab stores in A-minus centers average $1.2M+ in sales, while those in C-grade centers average under $700K. If you’re buying an existing My Eyelab franchise, review its historical traffic counts, lease renewal terms, and any nearby competitor openings since 2023. A store that once thrived may now face a new America’s Best or online disruptor within walking distance.

Financing Options & ROI Timeline for 2027 Buyers

Opening a My Eyelab franchise in 2027 requires $400,000–$700,000 total investment, with franchisees typically needing $150,000–$250,000 in liquid capital and a net worth of $500,000+. Financing options include SBA 7(a) loans (common for optical franchises, with 10–25 year terms at 8–12% interest in 2027), equipment leasing (frames, exam equipment, lab machinery: $80,000–$150,000), and franchisor-arranged loans through partner lenders. My Eyelab does not offer direct in-house financing, but Now Optics has relationships with several SBA-preferred lenders. For buying an existing franchise, expect a valuation of 2.5–4x seller’s discretionary earnings (SDE), with typical asking prices of $350,000–$650,000 for a mature store generating $150,000–$300,000 SDE. ROI timeline: new openings typically break even in months 12–18, with full payback on investment in 3–5 years. Existing stores with positive cash flow can yield 15–25% annual return on investment, but factor in a 10–15% premium for goodwill and transfer fees ($5,000–$15,000). A critical financial warning: My Eyelab’s telehealth model reduces doctor costs but increases technology and software subscription fees (telemedicine platform, inventory management, CRM) by $2,000–$4,000 per month. Ensure your pro forma includes these recurring costs, plus a 3–5% annual increase in frame/lens wholesale costs due to inflation. The best financing strategy for 2027: combine an SBA loan for 80% of startup costs with a home equity line of credit or retirement rollover (via ROBS) for the remaining 20%, keeping your cash reserve intact for working capital during the first 12 months.

FAQ

What is the total investment range to open a My Eyelab franchise? Based on the 2026 FDD, the total Item 7 investment typically falls between $400,000 and $700,000. This includes the franchise fee of $30,000 to $50,000, plus costs for build-out, equipment, inventory, and working capital. Actual amounts vary by location and lease terms.

How much can a My Eyelab franchise owner expect to earn? Mature centers generally report gross revenues of $800,000 to over $2,000,000 annually. Owner earnings after expenses and royalties typically range from $130,000 to $400,000, depending on location, management, and market conditions. These are honest estimates, not guarantees.

Do I need an optometrist on staff to run a My Eyelab? No, in many models the brand uses telehealth-enabled exams with remote doctors, so you don’t need an on-site optometrist. However, regulatory requirements vary by state, so you should verify local laws. This can reduce staffing complexity but requires reliable telemedicine technology.

What are the ongoing fees for a My Eyelab franchise? The royalty is typically 6% to 8% of gross sales, plus a marketing fee. These are standard for the optical franchise industry. Always review the current FDD for exact percentages, as they can change with new franchise agreements.

How does My Eyelab compete with other optical brands? It targets value-conscious consumers with affordable eyewear and same-day service, backed by the Now Optics group (also owner of Stanton Optical). Its telehealth advantage and recession-resilient vision demand help it compete, but it faces strong competition from other value and premium optical chains. Differentiation relies on technology and pricing.

What are the biggest challenges of owning a My Eyelab franchise? Key challenges include navigating telehealth regulations that vary by state, hiring and retaining staff, and competing with established optical retailers. The model’s success depends on location, local demand, and your ability to manage these operational hurdles.

Bottom Line

Open a My Eyelab if you want a tech-enabled, value-optical franchise with affordable eyewear, telehealth-assisted exams (where permitted), recession-resilient vision demand, an established optical group (Now Optics), and high-margin eyewear, you can navigate telehealth-optometry regulations, and you're in a value-conscious market. Its value positioning, telehealth efficiency, recession-resilient demand, and high-margin eyewear are genuine strengths. Skip it if your state restricts telehealth optometry without a plan, you can't compete with value/online eyewear, or you can't drive eyewear sales. Confirm telehealth regulations and validate Item 19. For retail-and-tech-minded operators who leverage value and telehealth in receptive markets, My Eyelab offers a value-optical path — the value positioning, telehealth/regulatory navigation, and eyewear sales are the keys.

Sources

flowchart TD A[Gross Revenue $1.3M Value Optical] --> B[Less Product Cost 34% = $442K] B --> C[Less Staff 25% = $325K] C --> D[Less Rent & Marketing 17% = $221K] D --> E[Less Royalty/Opex 12% = $156K] E --> F[Owner Earnings ~$156K-$350K] F --> G{Value demand + telehealth + regulations?} G -->|Strong| H[Value-optical returns] G -->|Weak| I[Regulatory + competition pressure]
flowchart LR D1[Day 1-20: Read FDD + Item 19 + Telehealth Rules] --> D2[Day 21-40: Call Operators] D2 --> D3[Day 41-60: Validate Value Market + Regulations] D3 --> D4[Day 61-100: Build + Staff + Telehealth] D4 --> D5[Day 101-130: Open + Customer Acquisition] D5 --> D6[Leverage Value + Telehealth Efficiency] D6 --> D7[Drive Eyewear Sales] ![Should I open or buy a My Eyelab franchise in 2027 — figure 4](/assets/qa/fr0965-b4.jpg)

Related on PULSE

Download:
Was this helpful?